Keywords
Acne vulgaris, hormone
Acne vulgaris, hormone
The study's title was changed to "Assessment of serum testosterone, estradiol, and progesterone levels in female patients with acne vulgaris". And for the inclusion criteria, we choose acne patients from 16 to 25 years old.
See the authors' detailed response to the review by Berna Aksoy
See the authors' detailed response to the review by Jerry Tan
See the authors' detailed response to the review by Mohamed Badawy Hassan Tawfik Abdel-Naser
Acne is a chronic inflammatory disorder of the pilosebaceous unit with various manifestations, including non-inflammation and inflammation lesions. Collier et al. (2008) investigated 1013 Americans aged 20 years and older; 73.3% (744) reported ever having acne, more women suffer from acne than men.1 Four major factors involved in acne pathogenesis are excessive sebum production, follicular hyperkeratinization, hyper-colonization of the duct by Cutibacterium acnes (formerly Propionibacterium acnes), and the production of inflammation.2 Moreover, the hormone plays a crucial role in the pathogenesis of acne. Some studies found that acne had a relationship with hyperandrogenemia in female patients.3 Estradiol, the primary female sex hormone is known as the major active estrogen, forms in absolute serum levels and estrogenic activity during human female reproductive years. Supplying sufficient amounts of estrogens will decrease sebum production and may act by suppressing androgen production by inhibiting the pituitary from secreting gonadotropin.4 The effect of progesterone on sebaceous glands was still disputed. Some authors have blamed progesterone for the change of sebum production in females during the menstrual cycle. However, this theory has not been proved experimentally.5 Therefore, we conducted this study to evaluate the serum testosterone, estradiol, and progesterone levels and the correlation of hormonal alterations with the severity of acne in women with acne vulgaris.
A cross-sectional study was conducted from January to October 2019 to concentrate serum estradiol, progesterone, testosterone levels in female acne patients at the Dermatology department of 103 military hospital, Vietnam.
The inclusion criteria for acne patients were females aged 16 to 25 years and diagnosed with acne vulgaris.
The control group’s criteria were healthy females without pregnancy or lactation.
Exclusion criteria were: diagnosis with (1) other types of acne; (2) patients with polycystic ovary syndrome; (3) using hormone contraceptives or other hormones; (4) a history of ovarian or pelvic surgery; (5) pregnant or breastfeeding women.
This was a prospective, cross-sectional descriptive study with control samples.
The sample size was based on the below formula and the research result of da Cunha (2013),5 we got n = 148.
All patients for each group were asked about risk factors, clinically examined, were performed tests (control group, acne group), and registered to study records.
The acne grading score, according to Karen McKoy (2008),6 is as follows:
• Mild: less than 20 noninflammatory lesions or less than 15 inflammatory lesions or less than 30 total kinds of lesions.
• Moderate: 20–100 noninflammatory lesions or 15–50 inflammatory lesions or 30–125 total kinds of lesions.
• Severe: more than 05 papules/cysts or more than 100 noninflammatory lesions/more than 50 inflammatory lesions or more than 125 total kinds of lesions.
Assessment technique of plasma hormone levels: 4 mL of venous blood was collected at 08:00 h and during the follicular phase of the menstrual cycle (2nd to 4th day of menses). Blood samples are contained in a tube with EDTA anticoagulant solution. After being incubated at room temperature for 10–20 minutes, samples are centrifuged for about 20 minutes at 2000–3000 rpm. After centrifuging, taking the plasma part for testing, we used direct chemiluminescent technology for measuring hormone levels in the Unicel® DXI800 machine. Units: testosterone for ng/dL, estradiol for pmol/L, progesterone for ng/mL.
210 female participants were enrolled in the study and divided into 175 female patients with acne vulgaris and 35 healthy controls.
The mean age of patients and BMI showed no statistically significant difference between the study group and the control group with p>0.05 (Table 1).
Characteristics | Acne group (n=175) | Control group (n=35) | p-value | Normal range |
---|---|---|---|---|
Average age (years) | 20.82±2.53 | 19.91±2.57 | >0.05 | |
BMI (kg/m2) | 19.33±1.51 | 18.90±1.62 | >0.05 | 18.5–24.9 |
The plasma testosterone level of the acne vulgaris patients was higher than the control group, respectively 55.67±25.56 ng/dL, 38.37±10.16 ng/dL. The difference was statistically significant with p<0.05. On the other hand, plasma estradiol level in acne vulgaris patients was lower than the control group with a statistically significant difference (p <0.05), respectively 323.15±93.31 pmol/L and 370.94±58.88 pmol/l. However, plasma progesterone levels were not different between both groups (Table 2).
52 patients (29.7%) out of 175 acne patients had hormonal alterations, including 28 patients (16%) with hyperandrogenism; 20 patients (11.43%) had increased serum progesterone level, only four patients (2.29%) had increased serum estradiol level, no patient had low hormonal levels (Table 3).
Value | Testosterone | Estradiol | Progesterone | Total (n=175) |
---|---|---|---|---|
Normal | 147 (84.0%) | 171 (97.71%) | 155 (88.57%) | 124 |
Increase | 28 (16.0%) | 4 (2.29%) | 20 (11.43%) | 52 (29.7%) |
Decrease | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
There were no different hormone levels between the grades of the acne vulgaris group and there were no different testosterone levels between the mild acne and control groups with p>0.05. However, testosterone levels in moderate and severe groups were statistically significantly higher than in the control group (p<0.05). Estradiol levels in the moderate and severe groups were statistically significantly lower than the control group with p<0.05. However, the estradiol level in the mild group was not significantly lower when compared with the control group. Progesterone levels in the mild and moderate groups were similar to the control group, except the severe group was higher than the control group; the difference was statistically significant with p<0.05 (Table 4).
The gonads and the adrenal gland produce the majority of circulating androgens. However, androgens can also be produced locally within the sebaceous gland from the adrenal precursor hormone DHEAS (dehydroepiandrosterone sulfate). The major androgens interacting with the androgen receptor are testosterone and DHT (dihydrotestosterone). In addition, androgen receptors have been localized to the basal layer of the sebaceous gland and the outer root sheath keratinocytes.7
In 2013, da Cunha et al. investigated androgen levels in 835 female patients with acne vulgaris and found that the rate of androgenism was 10.77%.5 In 2014, Wei et al. studied endocrine disorders in 242 acne patients. The authors showed that serum testosterone levels were significantly increased in the acne patient group compared with controls.8 In this study, we found that the testosterone level of the acne group was higher than controls and the hyperandrogenism rate was 16%.
We hypothesize that estrogens might impact sebum secretion by three different mechanisms: the opposition of androgens within the sebaceous glands, inhibition of gonadal androgen production via a negative feedback mechanism on gonadotropin release, and has an effect on genes which play a role in sebaceous gland growth and lipid production.9 In 2014, Wei et al. surveyed 118 female acne patients compared with 90 sex-matched controls. The results showed that the estradiol level in the acne group decreased significantly compared with the control group with a p-value less than 0.001, respectively 263.81±14.83 pmol/L; 398.71±26.24 pmol/L.8 This result was also consistent with our result.
Testosterone is converted into a more potent form DHT by 5-ARD (5α-reductase) enzyme causing an excess sebum production, whereas progesterone inhibits the activity of this enzyme and prevents turning testosterone into DHT. So, progesterone itself might be expected to reduce sebaceous gland activity. However, the progesterone effect on acne remains unclear. Although some studies show that progesterone can reduce androgen effects by inhibiting the 5-ARD enzyme or androgen receptors,10 the fluctuation of sebum production in women during the menstrual cycle and premenstrual cyclic flare has partly been associated with progesterone, and some progestins lead to an exacerbation of acne by interacting with androgen receptors.10,11 In our study, there was no statically significant difference between the acne group and controls in terms of serum progesterone levels. However, the progesterone level of the severe acne was higher than the control group; the difference was statically significant with p<0.05.
This study showed that the female acne vulgaris patients might have high serum testosterone levels and low serum estradiol levels compared with those of female controls. However, hormone levels differences had no correlation with acne grade.
Dryad: Underlying data for ‘Assessment of serum hormone levels in female patients with acne vulgaris’. https://doi.org/10.5061/dryad.bvq83bk9z12
The project contains the following underlying data:
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Approval was obtained from the ethics committee of Hanoi Department of Science and Technology with the code: 01C-08/14-2017-3. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
Written informed consent for publication of the patients’ details was obtained from the patients.
The authors would like to thank the Department of Dermatology and Venereology of 103 Military hospital, Military Medical University, for their support during the study and to the patients for their voluntary participation in this research.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Acne
Competing Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
No source data required
Are the conclusions drawn adequately supported by the results?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Acne
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
Version 5 (revision) 19 Jan 23 |
read | |||
Version 4 (revision) 22 Apr 22 |
read | |||
Version 3 (revision) 04 Apr 22 |
||||
Version 2 (revision) 09 Feb 22 |
read | read | ||
Version 1 11 Jan 22 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)